BSX Financial Facts
Other, net: -33MRoyalty expense: 20M
See Full Income Statement
See Full Balance Sheet
Boston Scientific (BSX) Earnings
|
Expand Research on BSX
| Next EPS Date | 7/29/26 | EPS Growth Rate | +10.7% |
|---|---|---|---|
| Average EPS % Beat Rate | +3.1% | Revenue Growth Rate | +6.3% |
| Average % Move 1-Wk after EPS | -4.1% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7/29/26 |
Q226 | N/A | $0.83 | N/A | N/A | $5.38B | = | N/A | N/A | ||
| 4/22/26 | Q126 | $0.80 | $0.79 | +$0.01 | $5.2B | $5.17B | = | ![]() | ![]() | Details | |
| 2/4/26 | Q425 | $0.80 | $0.78 | +$0.02 | $5.29B | $5.28B | = | ![]() | ![]() | Details | |
| 10/22/25 | Q325 | $0.75 | $0.71 | +$0.04 | $5.07B | $4.97B | = | ![]() | ![]() | Details | |
| 7/23/25 | Q225 | $0.75 | $0.73 | +$0.02 | $5.06B | $4.89B | = | ![]() | ![]() | Details | |
| 4/23/25 | Q125 | $0.75 | $0.67 | +$0.08 | $4.66B | $4.57B | = | ![]() | ![]() | Details | |
| 2/5/25 | Q424 | $0.70 | $0.66 | +$0.04 | $4.56B | $4.41B | = | ![]() | ![]() | Details | |
| 10/23/24 | Q324 | $0.63 | $0.59 | +$0.04 | $4.21B | $4.04B | = | ![]() | ![]() | Details |




